ABSTRACT

Aspergillosis refers to the spectrum of disease caused by Aspergillus species. The aspergilloma is the most common and best-recognized form of pulmonary involvement due to Aspergillus; usually developing in a preformed lung cavity and the principal association is with Tuberculosis. The true incidence of aspergilloma is not known. Although frequently asymptomatic, the presence of a fungus ball due to Aspergillus may cause hemoptysis and in cases can be fatal, with a variable mortality ranging between 9 to 30%. Aspergilloma usually comes to clinical attention as an incidental finding, thus the diagnosis involve clinical and radiological findings confirmed by pathology. There is no consistent evidence that aspergilloma. Responds to antifungal agents, and these drugs rarely achieve the minimal inhibitory concentrations within the lung cavities. Surgical resection, despite a high morbidity, is the only proven therapy for these cases.

KEYWORDS

Pulmonary aspergilloma, hemoptysis, surgical treatment, .

REFERENCES

1. Corder R. Hemoptysis. Emerg Med Clin N Am 2003; 21: 421-435.

2. Bidwell J, Pachner R. Hemoptysis: Diagnosis and management. Am Fam Physician 2005; 72: 1253-1260.

3. Soubani A, Chandrasekar P. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121: 1988–1999.

4. Flower C, Jackson J. The Role of Radiology in the investigation and management in patients with hemoptysis. Clin Radiol 1996; 51: 391-400.

5. Millar A, Boothroyd E, Edwards D. The role of computed tomography in the investigation of unexplained hemoptysis. Repir Med 1992; 86: 39-44.

6. Thompson III G, Patterson T. Pulmonary aspergillosis. Semin Respir Crit Care Med 2008; 29: 103–110.

7. Marr K, Patterson T, Denning D. Aspergillosis pathogenesis, clinical manifestations and therapy. Infect Dis Clin N Am 2002; 16: 875-894.

8. Barnes P, Marr K. Aspergillosis: Spectrum of disease, diagnosis and treatment. Infect Dis Clin N Am 2006; 20: 545-561.

9. Hope W, Walsh T, Denning D. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-622.

10. Zmeili O, Soubani A. Pulmonary aspergillosis: A clinical update. Q J Med 2007; 100: 317-334.

11. Kradin R, Mark E. The pathology of pulmonary disorders due to Aspergillus spp. Arch Pathol Lab Med 2008; 132: 606-614.

12. Chen J, Chang Y, Luh S, Lee J, Lee Y. Surgical treatment for pulmonary aspergilloma: a 28 year of experience. Thorax 1997; 52: 810-813.

13. Akbari J, Praveen K, Praveen N, Sankaran K. Clinical Profile and Surgical outcome for pulmonary aspergilloma: A single center experience. Ann Thorac Surg 2005; 80: 1067-72.

14. Kim Y, Kang M, Sung S, Kim J. Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma. Ann Thorac Surg 2005; 79: 294-298.

15. Kauffman CA. Quandary about treatment of aspergillomas persists. Lancet 1996; 347: 1640-5.

16. El Oakley R, Petrou M, Goldstraw P. Indications and outcome of surgery for pulmonary aspergilloma. Thorax 1997; 52: 813–815.

17. Addrizzo-Harris DJ, Harkin TJ, McGuinness G, et al. Pulmonary aspergilloma and AIDS: A comparison of HIV infected and HIV-negative individuals. Chest 1997; 111: 612–618.

18. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus: Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 696–709.